Gregorius P. M. Luyten

4.5k citations

114 papers · 3.0k indexed · h-index 32

Ophthalmology top 0.2%
Molecular Biology top 10%
Oncology top 5%
Immunology top 5%
Radiology, Nuclear Medicine and Imaging top 2%

Co-authors: Martine J. Jager Pieter A. van der Velden Inge H. G. Bronkhorst Ekaterina S. Jordanova Marina Marinkovic Mieke Versluis Annelies de Klein Wilma G. M. Kroes
Topics: Ocular Oncology and Treatments (84 papers)Immunotherapy and Immune Responses (26 papers)Glaucoma and retinal disorders (19 papers)
Cited by: Ophthalmology Immunology Oncology
Journals: SHILAP Revista de lepidopterologíaThe Journal of Immunology PLoS ONE
Partner nations: Netherlands United States France

In The Last Decade

Gregorius P. M. Luyten

113 papers receiving 2.9k citations

Peers

Countries citing papers authored by Gregorius P. M. Luyten

Since Specialization

Citations

This map shows the geographic impact of Gregorius P. M. Luyten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregorius P. M. Luyten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregorius P. M. Luyten more than expected).

Fields of papers citing papers by Gregorius P. M. Luyten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregorius P. M. Luyten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregorius P. M. Luyten. The network helps show where Gregorius P. M. Luyten may publish in the future.

Co-authorship network of co-authors of Gregorius P. M. Luyten

This figure shows the co-authorship network connecting the top 25 collaborators of Gregorius P. M. Luyten. A scholar is included among the top collaborators of Gregorius P. M. Luyten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregorius P. M. Luyten. Gregorius P. M. Luyten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PO-1587 two years of ocular proton therapy in The Netherlands, clinical results 2023 ·Radiotherapy and Oncology ·C. Rasch,(unknown),(unknown),Marina Marinkovic,Khanh Dang Vu,Jaco C. Bleeker,(unknown),(unknown),Jan‐Willem M. Beenakker,Nanda Horeweg,Gregorius P. M. Luyten	0
2	PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma 2023 ·Investigative Ophthalmology & Visual Science ·Maria Chiara Gelmi,Gülçin Gezgin,Pieter A. van der Velden,Gregorius P. M. Luyten,(unknown),Mirjam H.M. Heemskerk,Martine J. Jager	12
3	Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period 2023 ·Cancers ·(unknown),Esther Bastiaannet,Frank M. Speetjens,Christian U. Blank,Gregorius P. M. Luyten,Martine J. Jager,Marina Marinkovic,T. H. Khanh Vu,C. Rasch,Carien L. Creutzberg,Jan‐Willem M. Beenakker,Henk H. Hartgrink,(unknown),Emine Kılıç,Nicole C. Naus,Serdar Yavuzyiğitoğlu,Caroline M. van Rij,Mark C. Burgmans,Ellen Kapiteijn	1
4	Tumor-Infiltrating T Cells Can Be Expanded Successfully from Primary Uveal Melanoma after Separation from Their Tumor Environment 2022 ·SHILAP Revista de lepidopterología ·Gülçin Gezgin,Marten Visser,Dina Ruano,Saskia J. Santegoets,Noel F.C.C. de Miranda,Pieter A. van der Velden,Gregorius P. M. Luyten,Sjoerd H. van der Burg,Els M.E. Verdegaal,Martine J. Jager	14
5	Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma 2021 ·BMC Cancer ·(unknown),(unknown),Mieke Versluis,Gregorius P. M. Luyten,Robert M. Verdijk,Michele C. Madigan,Martine J. Jager,Pieter A. van der Velden	23
6	In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target 2021 ·Cancers ·(unknown),Annemijn P. A. Wierenga,(unknown),Pieter A. van der Velden,Gregorius P. M. Luyten,Robert M. Verdijk,Martine J. Jager	3
7	Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma 2021 ·Cancers ·(unknown),Aart G. Jochemsen,Annemijn P. A. Wierenga,Wilma G. M. Kroes,Robert M. Verdijk,Pieter A. van der Velden,Gregorius P. M. Luyten,Martine J. Jager	9
8	MiRNAs Correlate with HLA Expression in Uveal Melanoma: Both Up- and Downregulation Are Related to Monosomy 3 2021 ·Cancers ·(unknown),Annemijn P. A. Wierenga,Emine Kılıç,Erwin Brosens,Stefan Böhringer,Wilma G. M. Kroes,Robert M. Verdijk,Pieter A. van der Velden,Gregorius P. M. Luyten,Martine J. Jager	7
9	LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma 2021 ·Cancers ·(unknown),Annemijn P. A. Wierenga,Wilma G. M. Kroes,Pieter A. van der Velden,Robert M. Verdijk,Michael Eikmans,Gregorius P. M. Luyten,Martine J. Jager	37
10	Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time 2020 ·Ocular Oncology and Pathology ·(unknown),Annemijn P. A. Wierenga,Sjoerd G. van Duinen,Robert M. Verdijk,Jaco C. Bleeker,Marina Marinkovic,Gregorius P. M. Luyten,Martine J. Jager	18
11	HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma 2020 ·Cancers ·(unknown),Aart G. Jochemsen,(unknown),Annemijn P. A. Wierenga,Fariba Némati,Pieter A. van der Velden,Wilma G. M. Kroes,Robert M. Verdijk,Gregorius P. M. Luyten,Martine J. Jager	28
12	Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines 2019 ·Cancers ·Cindy Chau,Remco van Doorn,Natasha M. van Poppelen,Nienke van der Stoep,Arjen R. Mensenkamp,Rolf H. Sijmons,(unknown),Ans M.W. van den Ouweland,Nicole C. Naus,Annemieke H. van der Hout,Thomas P. Potjer,Fonnet E. Bleeker,Marijke R. Wevers,Liselotte P. van Hest,Marjolijn C.J. Jongmans,Marina Marinkovic,Jaco C. Bleeker,Martine J. Jager,Gregorius P. M. Luyten,Maartje Nielsen	39
13	Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma? 2019 ·Cancers ·(unknown),Annemijn P. A. Wierenga,(unknown),Thorbald van Hall,Pieter A. van der Velden,Wilma G. M. Kroes,Ulrich Pfeffer,Gregorius P. M. Luyten,Martine J. Jager	11
14	Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics 2019 ·Cancers ·Annemijn P. A. Wierenga,Gülçin Gezgin,Els van Beelen,Michael Eikmans,(unknown),Niels J. Brouwer,(unknown),Robert M. Verdijk,Sjoerd G. van Duinen,Marina Marinkovic,Gregorius P. M. Luyten,Martine J. Jager	16
15	Ischemia Is Related to Tumour Genetics in Uveal Melanoma 2019 ·Cancers ·Niels J. Brouwer,Annemijn P. A. Wierenga,Gülçin Gezgin,Marina Marinkovic,Gregorius P. M. Luyten,Wilma G. M. Kroes,(unknown),Pieter A. van der Velden,Robert M. Verdijk,Martine J. Jager	15
16	Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution 2019 ·Cancers ·Niels J. Brouwer,Gülçin Gezgin,Annemijn P. A. Wierenga,Inge H. G. Bronkhorst,Marina Marinkovic,Gregorius P. M. Luyten,(unknown),Wilma G. M. Kroes,Pieter A. van der Velden,Robert M. Verdijk,Martine J. Jager	27
17	The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status 2017 ·Investigative Ophthalmology & Visual Science ·Mehmet Doğrusöz,Mette Bagger,Sjoerd G. van Duinen,Wilma G. M. Kroes,Claudia Ruivenkamp,Stefan Böhringer,Klaus Kaae Andersen,Gregorius P. M. Luyten,Jens Folke Kiilgaard,Martine J. Jager	76
18	Tumor pigmentation in Uveal melanoma is related to eye color 2017 ·Investigative Ophthalmology & Visual Science ·Annemijn P. A. Wierenga,Mehmet Doğrusöz,Wilma G. M. Kroes,Sjoerd G. van Duinen,Gregorius P. M. Luyten,Martine J. Jager	1
19	A fish scale-derived scaffold for corneal reconstruction 2013 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Gregorius P. M. Luyten,Abdoelwaheb El Ghalbzouri,Martine J. Jager	1
20	Pre-clinical analysis of Crizotinib in MAPK independent uveal melanoma metastases 2013 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),Mieke Versluis,Gregorius P. M. Luyten,Martine J. Jager	1

About Gregorius P. M. Luyten

Gregorius P. M. Luyten is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 114 papers that have together received 3.0k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (84 papers), Immunotherapy and Immune Responses (26 papers) and Glaucoma and retinal disorders (19 papers). The work is most often cited by research in Ophthalmology (2.2k citations), Immunology (885 citations) and Oncology (946 citations). Gregorius P. M. Luyten has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Martine J. Jager, Pieter A. van der Velden, Inge H. G. Bronkhorst, Ekaterina S. Jordanova, Marina Marinkovic, Mieke Versluis, Annelies de Klein, Wilma G. M. Kroes, Sjoerd G. van Duinen and Long V. Ly. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact